For decades, excessive, unscientific regulation has slowed innovation using molecular genetic engineering. Policymakers must awaken to the realization that regulations based on pseudoscience or nescience are destructive and regressive. Tremendous innovations await, if only we have the wisdom to permit them to be developed.
regulation
The agency's primary functions are ensuring food safety, regulating tobacco products rationally, and expeditiously approving new drugs and medical devices. It's failing. Instead, we're getting increasingly complex organizational structures and the commissioning of endless reports.
A concerning shortage of Adderall, one of the drugs commonly used to treat attention deficit hyperactivity disorder (ADHD), is putting patients at risk. What caused it, and how can we fix it? The EPA has set new guidelines to keep PFAS out of drinking water. There's a problem, however: the agency's standards are absurd.
Panicked headlines recently warned that the popular artificial sweetener erythritol could increase heart disease risk. The study that generated these claims in no way supports that association. Dietary supplements are a multi-billion-dollar industry; they've also killed people. Do they need more regulatory oversight?
In 2016, the American viewing public was exposed to 663,000 television commercials for pharmaceuticals. That is a significant “ad spend” by Pharma, which we pay for through increased drug pricing. A new study looks at the therapeutic value of the more heavily advertised drugs. The key concept here is “market differentiation.”
The FDA actively – and unusually – collaborated with a biopharmaceutical company to pursue the approval of an Alzheimer's Disease drug, despite many questions about its efficacy and astronomical price. A congressional investigation found that the FDA’s approval process was “rife with irregularities" and that the agency’s actions “raise serious concerns about FDA’s lapses in protocol.”
It appears to defy logic that naloxone, the antidote for opioid overdoses, isn't available on demand. After all, it's a lifesaving drug with no potential for abuse. But it's not so simple, as Dr. Jeffrey Singer explains.
"It can disappear in a moment," Dr. Chuck Dinerstein said after his near-fatal battle with a pulmonary embolism. How should our mortality influence our worldviews? Unregulated medical devices may put patients in harm's way. Why is the Cleveland Clinic parroting anti-vaping talking points from the Truth Initiative?
President Biden recently took a small step in the right direction by acknowledging that people shouldn’t be caged for smoking cannabis and questioning the DEA classifying it as a Schedule 1 drug. Hopefully, it will spark Congress to take more definitive action.
A recent study examined the nutritional composition of meat and milk derived from gene-edited cattle bred to be hornless. The two-year-long project provided further evidence vindicating the safe use of biotechnology in food production.
Disease-resistant grapes are among the many genetically engineered plants that have yet to be commercialized. They would help the wine industry cut its pesticide use and expand production, lowering costs for both winemakers and consumers. Why haven't these GE grapes been approved?
A new report documents the hefty price countries pay for banning genetically engineered crops. The results aren't pretty, but they clearly illustrate the benefits of embracing biotechnology.